PhysioSonics, Inc., a privately held developer of noninvasive neurologic monitors, announced it has raised $2 million in a second tranche of series A financing. This follows a $4 million investment in 2008. The company is commercializing technologies including an ultrasound-based transcranial Doppler (TCD) monitor neuromonitor. In a press release, Brad Harlow, president & CEO of PhysioSonics said, "We are very excited with the continued validation of our product development as more neurosurgeons, anesthesiologists and cardiologists view our technology." The company was formerly known as Allez Physionix.
Related external links (will open a new window):
PhysioSonics, Inc. Raises $2.0 Million for Second Tranche of Series A Financing
Earthtimes (press release) - London, UK - July 1, 2009
Related WTC links:
PhysioSonics is a WTC client
- end of post -
>> Start a discussion on this topic
Related external links (will open a new window):
Earthtimes (press release) - London, UK - July 1, 2009
Related WTC links:
- end of post -
Labels: Allez_PhysiOnix, Company_and_Client_News, Funding, Life_Sciences, PhysioSonics
